#
Bupivacaine Injection
  • Drugs A to Z
  • Bupivacaine (Injection)

Bupivacaine (Injection)

Medically reviewed by Drugs.com. Last updated on Jan 8, 2022.

Injection route(Solution)

The 0.75% concentration of bupivacaine injection is not recommended for obstetrical anesthesia. Cardiac arrest with difficult resuscitation or death during use of bupivacaine for epidural anesthesia in obstetrical patients has been reported. The 0.75% concentration should be reserved for surgical procedures where a high degree of muscle relaxation and prolonged effect are necessary .

Commonly used brand name(s)

In the U.S.

  • Marcaine HCl
  • Marcaine Spinal
  • Sensorcaine
  • Sensorcaine-MPF

Available Dosage Forms:

  • Solution

Therapeutic Class: Anesthetic, Local

Chemical Class: Bupivacaine

Uses for bupivacaine

Bupivacaine injection is used to numb an area of your body during or after surgery or other procedures, childbirth, or dental work. Bupivacaine is also used to numb your shoulder after surgery for up to 72 hours. It is a local anesthetic.

Bupivacaine injection causes a loss of feeling and prevents pain by blocking signals at the nerve endings. It does not cause loss of consciousness.

Bupivacaine is to be given only by or under the direct supervision of your doctor.

Before using bupivacaine

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For bupivacaine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to bupivacaine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of bupivacaine injection during surgery and procedures in the pediatric population. Use is not recommended in children younger than 12 years of age. Safety and efficacy have not been established.

Appropriate studies have not been performed on the relationship of age to the effects of bupivaca..